Jordi Barquinero Mañez I am an MD, specialized in Internal Medicine, and senior researcher at the Vall d'Hebron Research Institute (VHIR). Doctor from the UAB with Extraordinary Award. I received post-doctoral training at the Fred Hutchinson Cancer Research Center (Seattle). I am currently leading the Gene and Cell Therapy group at the VHIR. My interest has focused on understanding disease mechanisms and finding effective therapies for orphan diseases. In our laboratory we have worked on gene therapy research projects for several rare diseases, mainly of genetic origin. Institutions of which they are part Head of group Gene and Cell Therapy Vall Hebron Institut de Recerca LinkedIn Twitter Orcid Jordi Barquinero Mañez LinkedIn Twitter Orcid Institutions of which they are part Head of group Gene and Cell Therapy Vall Hebron Institut de Recerca I am an MD, specialized in Internal Medicine, and senior researcher at the Vall d'Hebron Research Institute (VHIR). Doctor from the UAB with Extraordinary Award. I received post-doctoral training at the Fred Hutchinson Cancer Research Center (Seattle). I am currently leading the Gene and Cell Therapy group at the VHIR. My interest has focused on understanding disease mechanisms and finding effective therapies for orphan diseases. In our laboratory we have worked on gene therapy research projects for several rare diseases, mainly of genetic origin.
I am an MD specialized in Internal Medicine (Vall d'Hebron University Hospital). I worked at the Intensive Care Unit (HUVH) and the Emergency Department of the Hospital de l'Esperança. I did pre-doctoral studies on autoimmunity at the University of Louisville (Dr. N. Harris) and got my PhD at the Autonomous University of Barcelona with Extraordinary Award, with a work that contributed to the description of a new disease, the primary antiphospholipid syndrome. I was a postdoc at the Fred Hutchinson Cancer Research Center (Dr. R. Storb, Seattle), where I was trained in hematopoietic stem cell gene therapy. I am currently group leader of the gene and cell therapy group (VHIR), where we investigate new therapeutic strategies for rare genetic diseases, mostly in collaboration with other groups on campus and from other national and international institutions. We have participated in research projects using models of multiple sclerosis, hemophilia, MNGIE, in a clinical trial for Fanconi anemia type A (coordinated by Drs. J. Bueren and P. Río, at the CIEMAT (Madrid)), and more recently, in a novel gene therapy approach for muscular dystrophy due to merosin deficiency, in collaboration with the Pediatric Neurology group (Drs. F. Munell and D. Gómez). Our group is part of the national network TERAV (RICORS). I have participated in European projects (INHERINET, CONSERT), including one as coordinator (HEMO-IPS, e-Rare-2), in which we experimentally demonstrated the mutagenic mechanism of the "Royal disease", the form of hemophilia B that affected several European royal families in the 19th and 20th centuries. I participate as a teacher in different master's degrees and I am a member of the American and European Gene and Cell Therapy Societies, and was one of the founding members of the Spanish Society of Gene and Cell Therapy.
Projects Use of patient-specific induced pluripotent stem cells to improve diagnosis and treatment of hemophilia A (Hemo-Ips) IP: Jordi Barquinero Mañez Collaborators: Lluis Martorell Cedres, Sergio López Estévez Funding agency: Instituto de Salud Carlos III Funding: 177870 Reference: PI11/03024 (ERANET) Duration: 01/01/2012 - 30/06/2016 Nuevas estrategias basadas en las células mieloides supresoras expresando autoantígenos para inducir tolerancia. Aplicación en un modelo experimental de esclerosis múltiple IP: Jordi Barquinero Mañez Collaborators: Herena Eixarch Ahufinger Funding agency: Instituto de Salud Carlos III Funding: 134915 Reference: PI09/00237 Duration: 01/01/2010 - 31/12/2013 Estudi de la implicació de les cèl·lules T reguladores de tipus 1 (Tr1) en la inducció de tolerància antígen específica en el model animal de l'encefalomielitis autoimmune experimental (EAE) IP: Jordi Barquinero Mañez Collaborators: - Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 6243 Reference: 2008 BE 1 00114 Duration: 15/09/2008 - 13/05/2009 Unitat de Neuroimmunologia Clínica (UNiC) IP: Xavier Montalban Gairín Collaborators: Susana Otero Romero, Carlos Nos Llopis, Sunny Malhotra Sareen, Jaume Sastre Garriga, Jordi Rio Izquierdo, Ingrid Galán Cartaña, Rosalia Horno Ocaña, Manuel Comabella Lopez, Silvia Soler García, Carmen Tur Gomez, Jordi Barquinero Mañez, Herena Eixarch Ahufinger, Montserrat Moreno Sánchez, Mar Tintore Subirana, M Jesus Arevalo Navines, Carmen Espejo Ruiz, Angela Vidal Jordana, Joaquin Castillo Justribo, Mireia Castillo Juarez, Nicolás Miguel Fissolo, Georgina Arrambide García Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 43680 Reference: 2009 SGR 793 Duration: 01/01/2010 - 30/04/2014 Pagination First page « Previous page ‹ … Page 2 Page 3 Current page 4 Page 5 Page 6 … Next page › Last page »
